Advertisement
UK markets close in 7 hours 1 minute
  • FTSE 100

    8,089.41
    +49.03 (+0.61%)
     
  • FTSE 250

    19,672.72
    -46.65 (-0.24%)
     
  • AIM

    754.44
    -0.25 (-0.03%)
     
  • GBP/EUR

    1.1666
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2512
    +0.0050 (+0.40%)
     
  • Bitcoin GBP

    51,151.71
    -2,087.27 (-3.92%)
     
  • CMC Crypto 200

    1,363.30
    -19.28 (-1.40%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.17
    +0.36 (+0.43%)
     
  • GOLD FUTURES

    2,338.70
    +0.30 (+0.01%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    18,028.19
    -60.51 (-0.33%)
     
  • CAC 40

    8,071.13
    -20.73 (-0.26%)
     

Novartis’s Innovative Medicines Segment in 1Q18

Novartis’s Innovative Medicines Segment in 1Q18

Novartis’s (NVS) Innovative Medicines segment includes cardio-metabolic products, oncology products, immunology and dermatology products, respiratory products, neuroscience products, and established products.